NEWS COMMENTARY

DSM invests in plant-derived functional ingredients company Phynova

Published:
May 15, 2020
Coverage:
Emerging Ecosystems in Agrifood and Health More...
Activities:
Investment More...
Average importance

Building on a distribution agreement with Phynova in 2019, DSM led the €10 million investment in the Oxford-based company, which makes functional ingredients derived from plants. Phynova will use this funding to scale its mulberry leaf-derived ingredient "Reducose," which regulates blood glucose levels by reducing the impact of high-glycemic sugars. Phynova sells Reducose both as a supplement and as an ingredient for functional food and beverage products. As functional ingredients gain momentum, clients should explore offerings from developers employing traditional discovery methods as well as those from emerging startups like Brightseed that use an ingredient informatics-based approach to uncover novel functional phytonutrients.

For the original news article, click here .


Further Reading

Perfect Day is expanding into dairy fats

News Commentary | November 25, 2019

Given that dairy products are much more than just protein, Perfect Day is looking to round out its ingredient portfolio by adding fat production. However, the company resisted revealing how or when it intends to produce dairy fats with its fermentation platform. The company asserted that ... To read more, click here.

Perfect Day receives FDA approval for its fermentation-derived dairy protein

News Commentary | April 15, 2020

Perfect Day received "no objection" from the FDA for its dairy protein ingredient beta‑lactoglobulin, produced in an engineered strain of Trichoderma reesei. This definitive decision based on the company's self‑affirmed GRAS status is a key milestone as Perfect Day looks to ramp up production and ... To read more, click here.

Microbiome startup Solarea Bio raises $11.2 million Series A for "food as medicine" applications

News Commentary | October 26, 2020

This funding round was led by S2G Ventures and Bold Capital Partners. By leveraging bioinformatics, Solarea develops synergistic combinations of bacteria, fungi, and prebiotic fibers with anti‑inflammatory capabilities by studying microbial populations colonizing healthy foods. The company will use ... To read more, click here.